Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
Status:
Recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
Phase II, Multicenter, Open-label, Randomized Study evaluating neoadjuvant chemotherapy
(FOLFOX4) in patients with stage II and III colorectal cancer with standard chemoradiation
Defined by Magnetic Resonance Imaging